sensitivity of the sheep pulmonary vein antrum to acetylcholine stimulation. J Appl Physiol 105: 293-298, 2008. First published May 1, 2008 doi:10.1152/japplphysiol.01270.2007.-Isolation of the pulmonary vein antrum can terminate atrial fibrillation, but the rationale has not been elucidated. In the present study, we show that sheep atrial effective refractory period (ERP) was heterogeneously shortened by acetylcholine administration. After perfusion with 15 M acetylcholine, the shortest ERP occurred in the pulmonary vein antrum, which was recorded with the standard intracellular microelectrode technique (the ERP results in the pulmonary vein antrum, left atrial posterior wall, roof, free wall and appendage, and right atrial free wall were 52.0 Ϯ 1.6, 75.1 Ϯ 2.0, 77.2 Ϯ 1.7, 85.6 Ϯ 1.7, 64.3 Ϯ 2.1, and 90.5 Ϯ 1.3 ms, respectively; P Ͻ 0.05). Immunofluorescent staining revealed that muscarinic type 2 receptors (M2R) were also distributed heterogeneously in the atrial myocardium, with the highest density in the antrum (the relative fluorescent intensity results of the M2R in the pulmonary vein antrum, left atrial posterior wall, roof, free wall and appendage, and right atrial free wall were 62.64 Ϯ 2.56, 53.12 Ϯ 2.76, 51.83 Ϯ 2.45, 47.90 Ϯ 2.33, 55.27 Ϯ 2.08, and 45.53 Ϯ 2.02, respectively; P Ͻ 0.05), which was in accordance with the heterogeneity of ERP distribution. Thus the pulmonary vein antrum is a unique electrophysiological region with high sensitivity to acetylcholine, and its intensive response to acetylcholine is most likely associated with the dense M2R distribution of this region. Such an acetylcholine-induced ERP heterogeneity is possibly a substrate for atrial fibrillation and hence one of the potential electrophysiological bases for the isolation therapy. atrial fibrillation; pulmonary vein antrum; effective refractory period; muscarinic type 2 receptor ATRIAL FIBRILLATION IS THE most common arrhythmia encountered in clinical practice. It can cause complications such as congestive heart failure and stroke (7, 24) . Catheter ablation is thought to be a breakthrough in the history of the treatment of the arrhythmia (30). Although the technique has been modified, its critical point is isolation of the pulmonary vein antrum (4, 8, (25) (26) (27) . Association of cholinergic nerves with atrial fibrillation has been well documented in, for example, humans, canine, and sheep (17, 19, 27, 32) . In human heart, cholinergic nerve fibers distribute mainly in the left atrial posterior wall (LAPW), especially in the pulmonary vein antrum or the vicinity (5, 29). Cholinergic denervation achieved by catheter ablation can effectively reduce the recurrence of the arrhythmia (27). We hypothesize that cholinergic nerves may alter the electrophysiological activity of the pulmonary vein antrum via muscarinic type 2 receptors (M 2 R). The activation of the receptor produces an electrophysiological substrate involved in the initiation or maintenance of the arrhythmia, whereas isolation of the pulmonary vein antrum may block the interaction of the electrophysiological substrate with other parts of the atria. In this study, we investigated the electrophysiological response of the sheep pulmonary vein antrum to cholinergic agonists and found that its effective refractory period (ERP) was reduced more than in other locations of the atrium. This heterogeneity in electrophysiological response is correlated with the distribution of the M 2 R. These results are consistent with our hypothesis.
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MATERIALS AND METHODS
All procedures for animals were approved by the Animal Ethics and Experimentation Committee of the Tongji University, Shanghai, China, and were performed in accordance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (publication no. 85-23, revised 1996) . The research protocol for humans was reviewed and approved by the Ethical Committee at the Tongji University School of Medicine, Shanghai, China, and conformed to the guidelines of the World Medical Assembly (the Declaration of Helsinki).
Tissue preparation. Young sheep weighing 13-17 kg were anesthetized with pentobarbital sodium. Mechanical ventilation was applied with an incubated endotracheal tube. Thoracotomy was performed on all animals via the sternum. For the immunofluorescent staining of M 2R, sheep hearts were continuously perfused with a Langendorff apparatus with 36.5°C Tyrode solution (in mM: 145 NaCl, 4.5 KCl, 2. 5 CaCl 2, 1.0 MgCl2, 20 HEPES, 11.1 glucose, pH 7.35, 95% O 2-5% CO2) through the coronary artery for 5-10 min. For the intracellular microelectrode recording, sheep hearts were quickly excised and stored in oxygenated (95% O 2-5% CO2) cold above Tyrode solution. The sheep pulmonary vein antrum, LAPW, left atrial roof, left atrial free wall (LAFW), left atrium appendage (LAA), and right atrial free wall (RAFW) were isolated under a stereoscopic microscope, respectively. The isolation procedure took no longer than 15 min.
The research also included the pulmonary vein antrum, LAPW, roof, LAFW, LAA, and RAFW of human hearts of both sexes (4 women, 2 men) from 10 to 40 years of age, which were taken from cadavers without basal heart disease.
Intracellular microelectrode recordings. Standard intracellular microelectrode recording techniques were used (16) . The voltage signal was amplified with a DC preamplifier and head stage (NL102; Digitimer, Welwyn Garden City, UK) and analyzed by a PowerLab/ 8SP data-acquisition system (Chart software, version 5.0; AD Instruments, Colorado Springs, CO). All samples were stimulated at 1 Hz with square-wave pulses of 1 ms in duration and with the amplitude at two times the threshold. Glass capillary microelectrodes with tip resistances of 10 -20 M⍀ and filled with 3 M KCl were used to impale into endocardial surface. Experiments were started after 2 h of perfusion in 36.5°C Tyrode solution as mentioned above. After the sample was perfused with 15 M acetylcholine for 30 min, resting membrane potential, action potential amplitude, action potential duration (APD) at 50% and 90% of repolarization (APD 50 and APD90, respectively), and ERP were acquired. One cell was recorded at each of the following sites: the pulmonary vein antrum, LAPW, roof, LAFW, LAA, and RAFW (one cell each site from one sheep). The ERP was measured with 15 basic (S 1) stimuli followed by a premature (S2) stimulus at an S1S2 interval that was decreased by 1-to 10-ms decrements from the basic cycle length, with the ERP defined as the longest S 1S2 interval failing to produce a new, propagated action potential. The ERP was determined twice at each basic cycle length, and the mean of the ERP values was used for data analysis.
Pharmacological studies. To examine the EC 50, tissues from pulmonary vein antrum and other atrial regions were discretely perfused with different doses of acetylcholine for ϳ10 min and then washed out for 5 min. With the increase of acetylcholine concentration, the ERP did not further shorten, and a plateau response was achieved. As for the determination of IC 50, with 15 M acetylcholine preadministered for 10 min and subsequent constant administration, tissues from pulmonary vein antrum and other atrial regions were perfused with different muscarinic receptor blockers for ϳ10 min and then washed out for 5 min. The dose-response curves were acquired via logistic equation.
Immunofluorescent staining for M 2R in the atrium. We analyzed the distribution of the M2R in the pulmonary vein antrum, LAPW, roof, LAFW, LAA, and RAFW in sheep (n ϭ 6) and humans (n ϭ 6) by immnunohistochemistry and confocal laser scanning biological microscopy, following modifications to previous methods (6) . After the pericardium and fatty tissue were eliminated from the surface of the atrium, the atrium specimens were fixed by 4% paraformaldehyde in PBS for 24 h and embedded in paraffin. Five-micrometer-thick sections were then sliced from each block. After samples were immersed in dimethylbenzene and graded ethanol successively, slides of the pulmonary vein antrum, LAPW, roof, LAFW, LAA, and RAFW were sequentially treated as follows: 1) exposure to 0.01 mol/l citrate buffer (pH 6.0) at 95°C for 15 min, 2) blocking nonspecific antigen by 10% normal rabbit serum for 10 min, 3) incubation overnight at 4°C with M 2R (Sigma-Aldrich), muscarinic type 3 receptors (M3R; MBL), muscarinic type 4 receptors (M4R; MBL), GIRK3.1 (US Biological), GIRK3.4 polyclonal antibody (1:100; Santa Cruz Biotechnology), and distilled water (negative control). Rat hippocampus was used as a positive control. Slides of different sites were treated with the same antibody at the same time. Thereafter, slides were reacted with goat anti-rabbit IgG-FITC (1:100; Santa Cruz Biotechnology) for 45 min at room temperature. Signals were visualized at 500 -550 nm by FV1000 confocal laser-scanning biological microscope (Olympus). Immunofluorescence was analyzed from 50 cardiomyocytes of each slide in five slides of each atrial site. Moreover, the fluorescence of slides on the same sample was measured three times over 3 days. The cellular fluorescent intensity was evaluated by ImageJ 1.34 software (National Institutes of Health) (1, 20) .
Statistics. Data are expressed as means Ϯ SE. Statistical analysis of data was performed by applying one-way ANOVA followed by Student-Newman-Keuls post hoc test. A P value of Ͻ0.05 was considered statistically significant.
RESULTS

Electrophysiological response of the pulmonary vein antrum to M 2 R agonist.
We examined the effect of acetylcholine, an M 2 R agonist, on the parameters of action potential and ERP of the sheep atrial myocardium using the standard intracellular microelectrode recording technique. Figure 1 displays the backsides of the atrium and the pulmonary vein antrum in the sheep. Figure 2 shows a dose-response curve and a time dependence of the effect of acetylcholine on the ERP in cardiomyocytes of sheep pulmonary vein antrum, LAPW, roof, LAFW, LAA, and RAFW. In the present study, we used the data from the left superior pulmonary vein antrum to represent the different pulmonary vein antrums. The data from the left superior pulmonary vein antrum were similar to those from the other pulmonary vein antrums. The pulmonary vein antrum displayed a maximum response to acetylcholine stimulation. The ERP stayed stable, without significant changes for 30 min after application of 15 M acetylcholine. Without treatment of acetylcholine, no significant difference in the ERP was observed among the pulmonary vein antrum, LAPW, roof, LAFW, and LAA (P Ͼ 0.05), except that the RAFW showed a longer ERP than the left atrium (the pulmonary vein antrum, LAPW, roof, LAFW, and LAA) (P Ͻ 0.05). After perfusion with 15 M acetylcholine, ERP results in pulmonary vein antrum, LAPW, roof, LAFW, LAA, and RAFW were 52.0 Ϯ 1.6, 75.1 Ϯ 2.0, 77.2 Ϯ 1.7, 85.6 Ϯ 1.7, 64.3 Ϯ 2.1, and 90.5 Ϯ 1.3 ms, respectively. Acetylcholine obviously shortened the ERP in the atrial myocytes, especially in the pulmonary vein antrum (from 104.0 Ϯ 2.1 to 52.0 Ϯ 1.6 ms), resulting in a pronounced heterogeneity in the ERP among different sites of the atrial myocardium. Similarly, resting membrane potential, action potential amplitude, APD 50 , and APD 90 also showed heterogeneity in spatial distribution (Fig. 3 and Table 1 ). Values are means Ϯ SE; n ϭ no. of sheep. Antrum, left superior pulmonary vein antrum (data from antrum were similar to those from the other pulmonary vein antrums); LAPW, left atrial posterior wall; roof, left atrial roof; LAFW and RAFW, left and right atrial free wall; LAA, left atrial appendage; RP, resting potential; APA, action potential amplitude; APD90 and APD50, action potential duration and 90% and 50% repolarization; ERP, effective refractory period. *P Ͻ 0.05 vs. RAFW; †P Ͻ 0.05 vs. antrum.
We also noted that, after acetylcholine was washed out, action potential parameters and ERP of sheep atrial cardiomyocytes returned to original levels before treatment with acetylcholine. Another M 2 R agonist, carbachol (1 M), also produced an effect (Table 2 ) similar to acetylcholine, whereas the M 2 R blocker methoctramine (1 M) and the selective blocker of the acetylcholine-activated potassium current (I K-ACh ) tertiapin-Q (0.15 M) abolished the effect of acetylcholine (15 M) (data not shown).
To further test which type of muscarinic receptors is responsible for the effects of acetylcholine, we used the M 2 R, M 3 R, and M 4 R blockers to inhibit the acetylcholine-induced ERP shortening. The results showed that IC 50 values for methoctramine, an M 2 R blocker, 4-diphenylacetoxy-N-methylpiperidine, an M 3 R blocker, and tropicamide, an M 4 R blocker, were 0.151, 1.063, and 2.497 M (Fig. 4) (Fig. 5, A-G) . A similar distribution of the M 2 R was also found in human hearts (Fig.  5, H-N) . The coefficient of variation of the fluorescence was 5.07-12.31% for the same sample. In contrast, the expression of M 3 R, M 4 R, GIRK3.1, and GIRK3.4 showed no significant difference among different sites (data not shown).
DISCUSSION
In the present study, we for the first time demonstrated that atrial ERP was heterogeneously shortened by cholinergic agonist administration, with the shortest ERP occurring in the pulmonary vein antrum. In conformity with the heterogeneity of ERP distribution, M 2 R also heterogeneously distributed in the atrial myocardium, and the highest density of M 2 R was found in the pulmonary vein antrum, indicating that acetylcholine-induced heterogeneous ERP distribution may be a consequence of heterogeneous distribution of M 2 R. However, other muscarinic receptors, M 3 R and M 4 R, and I K-Ach channel subunits, GIRK3.1 and GIRK3.4, demonstrated no significant differences of spatial distribution in the atrium.
The heterogeneous shortening of ERP by acetylcholine as a consequence of the heterogeneity of M 2 R distribution is also supported by the following results. First, the M 2 R agonist carbachol could produce an effect similar to that of acetylcholine. Second, the effect of acetylcholine was inhibited by the M 2 R blocker methoctramine with a much higher sensitivity than by the M 3 R or M 4 R blockers 4-diphenylacetoxy-N-methylpiperidine or tropicamide. Third, the inhibition of I K-Ach channel, which is activated by the M 2 R signaling pathway, by tertiapin-Q also effectively abolished the effect of acetylcholine. These results were supported by the present findings on muscarinic expression, left atrial refractory period, and I K-Ach channel blockade (2, 9, 10).
Recently, Mansour et al. (22) identified sequential wave fronts with similar spatial patterns of propagation and temporal periodicity during atrial fibrillation in the isolated sheep heart by combining high-resolution video imaging, electrocardiographic recordings, and spectral analyses. These results showed a high degree of spatiotemporal periodicity accompanying atrial fibrillation, which thereby led to the hypothesis that atrial fibrillation maintenance depends on the uninterrupted periodic activity of a single or small number of reentrant sources to give rise to fibrillatory conduction through interactions with anatomic and/or functional obstacles (24, 15) . Increasing studies of animals and humans have demonstrated that the pulmonary vein antrum or junction of pulmonary vein left atrium is the leading reentrant source (7, 12, 17, 21) . Most of (24) . On the other hand, the refractory heterogeneity has also become a subject of attention, which may be associated with fractionation of wave fronts and fibrillatory conduction (17, 19) . The present study identified a marked ERP shortening in the pulmonary vein antrum (104.0 Ϯ 2.1 ms before acetylcholine application vs. 52.0 Ϯ 1.6 ms after acetylcholine application) and a distinct refractory heterogeneity between the pulmonary vein antrum (ERP in the pulmonary vein antrum: 52.0 Ϯ 1.6 ms) and its vicinity (ERP in the LAPW, roof, LAFW, LAA, and RAFW: 75.1 Ϯ 2.0, 77.2 Ϯ 1.7, 85.6 Ϯ 1.7, 64.3 Ϯ 2.1, and 90.5 Ϯ 1.3 ms, respectively) as induced by acetylcholine. Thus the pulmonary vein antrum may be a site with high response to acetylcholine. Remarkable ERP shortening induced by acetylcholine (from 104.0 Ϯ 2.1 to 52.0 Ϯ 1.6 ms), which is consistent with the clinical findings (28), together with the ERP heterogeneity, may be inclined to promote reentry and ultimately atrial fibrillation. The therapeutic effect of the pulmonary vein antrum isolation is most likely attributed to the isolation of the atrial fibrillation substrates within the pulmonary vein antrum (cholinergic stimulation-induced ERP shortening) and the abolition of the electrophysiological basis for fractionation of wave fronts and fibrillatory conduction (cholinergic stimulation-induced refractory heterogeneity).
In summary, the pulmonary vein antrum is a region of unique electrophysiological importance with high sensitivity to acetylcholine stimulation. The dense M 2 R distribution in the pulmonary vein antrum is most likely to be responsible for such high sensitivity to acetylcholine. Cholinergic stimulation induced dramatic ERP heterogeneity in the atrium, which may be a possible substrate for atrial fibrillation. Our work also presents the potential value of cholinergic antagonists in the treatment of certain types of atrial fibrillation.
Limitations
The relationship between ERP and atrial fibrillation has been identified previously, and our study suggested that cholinergic stimulation induced dramatic ERP heterogeneity in the atrium. However, the direct relationship between muscarinic receptor distribution heterogeneity and atrial fibrillation was not established in the present study.
Arora et al. (2) showed that M 2 R is predominantly located in the LAPW, whereas Huang et al. and Zhao et al. demonstrate that M 2 R is more abundant in atrial appendage than in other sites (11, 32) . However, the present study showed that M 2 R density in the pulmonary vein antrum was the highest. It is possible that this discrepancy is attributed to species differences. 
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